A new clinical trial by Imperial College London will explore whether psilocybin therapy could prevent relapse in opioid addiction. The landmark UK study will test if psilocybin, combined with psychological support, can help recently detoxed patients stay clean. With current relapse rates as high as 90% within a year of detox, researchers aim to combat the global opioid crisis that contributes to nearly 500,000 deaths annually.